Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-106143
Filing Date
2024-09-12
Accepted
2024-09-12 21:00:29
Documents
2
Period of Report
2024-09-12

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2838
2 EX-24 ck0002023658-ex24.htm EX-24 14498
  Complete submission text file 0000950170-24-106143.txt   18778
Mailing Address C/O DICE THERAPEUTICS, INC. 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address
Robertson Scott M. (Reporting) CIK: 0001882035 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42271 | Film No.: 241296247

Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 617-785-8308
Bicara Therapeutics Inc. (Issuer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)